Table 2.
Diagnostic test results in the study
| POCT | Intervention (N = 551) |
|
|---|---|---|
| Done, n (%) | Positive, n (%) | |
| Pathogen-specific POCTs | ||
| Malaria Pf/Pan Ag test | 551 (100) | 287 (52.1) |
| SARS-CoV-2 Ag test | 540 (98.0) | 23 (4.3) |
| Typhoid IgM test | 284 (51.5) | 20 (7.0) |
| Group A Strep Ag test | 20 (3.6) | 1 (5.0) |
| Influenza A/B Ag test | 148 (26.9) | 5 (3.4) |
| RSV Ag test | 49 (8.9) | 0 (0.0) |
| S. pneumoniae Ag test | 10 (1.8) | 1 (10.0) |
| Dengue IgM Ag test | 28 (5.1) | 2 (7.1) |
| Dengue NS-1 Ag test | 27 (4.9) | 1 (3.7) # |
| Non-pathogen specific tests | ||
| Done, n (%) | Median (Q1, Q3) | |
| C-Reactive protein [mg/L] | 517 (93.8%) | 28.6 (4.9, 84.0) |
| White Blood Cell counts [x109/L] | 517 (93.8%) | 8.8 (6.5, 11.6) |
| Neutrophil counts [%] | 517 (93.8%) | 55.0 (41.0, 66.0) |
#: The patient tested positive for Dengue NS-1 Ag test also is tested positive for Dengue IgM Ag test